Targeting oncogenic mutations in colorectal cancer using cryptotanshinone.
Colorectal cancer (CRC) is one of the most prevalent types of cancer in the world and ranks second in cancer deaths in the US. Despite the recent improvements in screening and treatment, the number of deaths associated with CRC is still very significant. The complexities involved in CRC therapy stem...
Main Authors: | Haswanth Vundavilli, Aniruddha Datta, Chao Sima, Jianping Hua, Rosana Lopes, Michael Bittner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0247190 |
Similar Items
-
An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines
by: Radhika S. Saraf, et al.
Published: (2018-08-01) -
Comprehensive live-cell imaging analysis of cryptotanshinone and synergistic drug-screening effects in various human and canine cancer cell lines.
by: Michael L Bittner, et al.
Published: (2021-01-01) -
A Bayesian approach to determine the composition of heterogeneous cancer tissue
by: Ashish Katiyar, et al.
Published: (2018-03-01) -
Activating mutation in <it>MET </it>oncogene in familial colorectal cancer
by: Schildkraut Joellen M, et al.
Published: (2011-10-01) -
Stimulation of Eryptosis by Cryptotanshinone
by: Rosi Bissinger, et al.
Published: (2014-07-01)